ARS Pharmaceuticals Novice Eulerpool

ARS Pharmaceuticals Novice o delnici

ARS Pharmaceuticals spremljajo številni novinarji in vlagatelji po vsem svetu. Najnovejše ARS Pharmaceuticals novice zbiramo in objavljamo tukaj.

• 14. november ·

  Yahoo
  ARS Pharmaceuticals Inc (SPRY) Q3 2024 Earnings Call Highlights: Strong Cash Position and NEPHI ...
• 13. november ·

  SeekingAlpha
  ARS Pharmaceuticals, Inc. (SPRY) Q3 2024 Earnings Call Transcript
• 13. november ·

  Yahoo
  ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Misses Revenue Estimates
• 13. november ·

  Yahoo
  ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
• 12. november ·

  Yahoo
  ARS Pharmaceuticals announces agreement with ALK to commercialize neffy
• 11. november ·

  Yahoo
  ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024
• 11. november ·

  Yahoo
  ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States
• 6. november ·

  Yahoo
  Wall Street Analysts Think ARS Pharmaceuticals, Inc. (SPRY) Could Surge 67.56%: Read This Before Placing a Bet
• 6. november ·

  Yahoo
  ARS Pharmaceuticals Announces Conference Call and Webcasts for its Third Quarter 2024 Financial Results and Presentations at Upcoming Conferences
• 5. november ·

  SeekingAlpha
  Aquestive: Rare Opportunity With Dual Platform Strategy